Osaic Holdings’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Sell
19,985
-3,137
-14% -$40K ﹤0.01% 3942
2025
Q4
$208K Buy
23,122
+2,755
+14% +$37.9K ﹤0.01% 4130
2025
Q3
$314K Buy
20,367
+303
+2% +$3.73K ﹤0.01% 3829
2025
Q2
$188K Buy
20,064
+2,373
+13% +$19.5K ﹤0.01% 3995
2025
Q1
$126K Buy
17,691
+10,697
+153% +$108K ﹤0.01% 4006
2024
Q4
$81.4K Sell
6,994
-28,361
-80% -$443K ﹤0.01% 4345
2024
Q3
$727K Sell
35,355
-1,774
-5% -$40.9K ﹤0.01% 2533
2024
Q2
$831K Sell
37,129
-30
-0.1% -$714 ﹤0.01% 2339
2024
Q1
$1.02M Buy
37,159
+1,278
+4% +$35.5K ﹤0.01% 2303
2023
Q4
$1.09M Buy
35,881
+11,878
+49% +$341K ﹤0.01% 2431
2023
Q3
$759K Buy
24,003
+3,978
+20% +$154K ﹤0.01% 2882
2023
Q2
$818K Sell
20,025
-1,323
-6% -$53.6K ﹤0.01% 2697
2023
Q1
$794K Buy
21,348
+1,034
+5% +$40.6K ﹤0.01% 2694
2022
Q4
$709K Buy
20,314
+12,722
+168% +$605K ﹤0.01% 2710
2022
Q3
$423K Buy
7,592
+15
+0.2% +$931 ﹤0.01% 3046
2022
Q2
$391K Sell
7,577
-1,068
-12% -$54.2K ﹤0.01% 3172
2022
Q1
$826K Buy
8,645
+88
+1% +$7.46K ﹤0.01% 2748
2021
Q4
$1.01M Buy
8,557
+360
+4% +$45.1K ﹤0.01% 2392
2021
Q3
$1.1M Sell
8,197
-2,389
-23% -$362K ﹤0.01% 2256
2021
Q2
$1.72M Sell
10,586
-1,311
-11% -$102K ﹤0.01% 1852
2021
Q1
$954K Buy
11,897
+810
+7% +$54.4K ﹤0.01% 2269
2020
Q4
$602K Buy
11,087
+1,466
+15% +$53.2K ﹤0.01% 2475
2020
Q3
$191K Sell
9,621
-291
-3% -$6.07K ﹤0.01% 3292
2020
Q2
$208K Sell
9,912
-3,627
-27% -$61.6K ﹤0.01% 3102
2020
Q1
$168K Buy
+13,539
New +$182K ﹤0.01% 3034

Other funds holding NTLA